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Abstract The earlier reported inhibition of rat liver nucleotide
pyrophosphatase/phosphodiesterase I (EC 3.1.6.9/EC 3.1.4.1;
NPP/PDE) by culture-grade acidic fibroblast growth factor
(FGF-1) correlates with a low-Mr contaminant. 1H-NMR
analyses revealed EDTA in the total-volume fractions of a gel-
filtration experiment, where all the inhibitory activity of the
FGF-1 preparation was recovered. NPP/PDE inhibition by
EDTA (and by unfractionated FGF-1 or the EDTA-containing
fractions) was time-dependent, blocked by the substrate p-
nitrophenyl-dTMP, and strongly enhanced by glycine. The use of
glycine buffers in earlier work was critical to the apparent
inhibition by FGF-1. The results point to a conformational
change favored by glycine that may be relevant to the biological
role of NPP/PDE.
z 1998 Federation of European Biochemical Societies.
Key words: Nucleotide pyrophosphatase; Phosphodiesterase
I; Fibroblast growth factor, acidic; Glycine; EDTA; Rat liver
1. Introduction
Nucleotide pyrophosphatase/phosphodiesterase I (EC
3.1.6.9/EC 3.1.4.1; NPP/PDE) enzymes hydrolyze both phos-
phoanhydrides and phosphodiesters of 5P-nucleotides. Much
attention is centered on a group of mammalian NPP/PDE
identical [1^5] or closely related [6^8] to the mouse plasma-
cell di¡erentiation antigen PC-1 [9,10], a membrane glycopro-
tein also expressed in other tissues including liver [11]. PC-1
and homolog NPP/PDE enzymes are capable of autophos-
phorylation and autoadenylylation in a threonine residue
[3,4,12], which may represent regulatory mechanisms and/or
catalytic intermediates [5,6,12,13]. These enzymes appear
linked to the pathogenesis of insulin resistance [14], tumor
metastasis [6] and the modulation of physiologic and patho-
logic bone and cartilage mineralization [15].
Concerning NPP/PDE regulation, FGF-1 was reported to
a¡ect bovine and rat liver PC-1 di¡erently: slight activation
[3] and strong inhibition [4], respectively. Recently, we (and
others [16]) reinvestigated the e¡ect of FGF-1 on rat liver
NPP/PDE and found that the commercial FGF-1 reported
to inhibit rat PC-1 [4] contains a low-Mr, non-protein con-
taminant identi¢ed as an NPP/PDE inhibitor. While Stefan et
al. hypothesized that it could be EDTA but could not char-
acterize it [16], we have demonstrated that: (i) the inhibitory
FGF-1 preparation did indeed contain EDTA, which ac-
counted for the inhibition, (ii) potent NPP/PDE inhibition
by EDTA required glycine which, used as a bu¡er in [4],
was critical for the observation of inhibition by EDTA-con-
taining FGF-1. Glycine-enhanced inhibition by EDTA re-
vealed indirectly a novel e¡ect of the amino acid on the con-
formation of NPP/PDE.
2. Materials and methods
2.1. Materials
Rat liver NPP/PDE was puri¢ed by an abridged version of a pub-
lished procedure [17]. In short, membranes were isolated from a rat
liver homogenate prepared in isotonic sucrose. NPP/PDE was ex-
tracted from the membranes with Triton X-100, solubilized by limited
trypsinization, adsorbed to a DEAE-cellulose column in 20 mM Tris-
HCl, pH 8.7, 5 mM MgCl2 (bu¡er A), eluted with a 0^400 mM NaCl
linear gradient in bu¡er A, concentrated by ultra¢ltration in a PM30
membrane (Amicon), chromatographed in a Sephacryl S-200 column
in bu¡er A, concentrated again, and bu¡er exchanged to 5 mM so-
dium phosphate, pH 8.25, in a Sephadex G-25 column (PD10, Phar-
macia). The speci¢c activity was 13 U/mg (assayed as in Section 2.2).
The enzyme, supplemented with BSA (1 mg/ml) and stored at 320‡C,
was stable for at least 1 year. Once thawed, each enzyme aliquot was
kept at 4‡C and was stable for at least 1 month. Prior to use, the
enzyme was diluted about 50-fold in 50 mM Tris-HCl, pH 9 (37‡C).
p-Nitrophenyl-dTMP (ammonium salt) was from Sigma. Glycine,
Tris, BSA (fraction V) and culture-grade FGF-1 (ref. 1033476; also
named endothelial cell growth factor; the one reported to inhibit rat
PC-1 [4,16]) were from Boehringer. EDTA (disodium salt) was from
Merck. All other reagents were of analytical grade from standard
commercial suppliers.
2.2. NPP/PDE assay
In all cases, NPP/PDE was assayed by its PDE activity at 37‡C,
under conditions of linearity with incubation time and amount of
enzyme, in 50 mM Tris-HCl, pH 9, 1 mM p-nitrophenyl-dTMP and
other additions as indicated. The reaction was started by the addition
of substrate (from a 50 mM stock solution) and stopped with 5 vol-
umes of 0.2 M NaOH. The formation of p-nitrophenol was measured
at 405 nm (O= 18.5 mM31 cm31). Blanks without enzyme and/or
substrate were processed in parallel. One unit enzyme activity was
de¢ned as 1 Wmol of substrate/min.
2.3. Treatment of NPP/PDE with EDTA or FGF-1
Treatment of NPP/PDE with EDTA or FGF-1 was carried out in
the reaction mixtures described above, prior to the addition of the
substrate. When indicated, 5 mM glycine (from a 100 mM stock
solution adjusted to pH 9 at 37‡C with NaOH) was also included
in these mixtures. The addition of enzyme (about 4^8 mU/ml of re-
action mixture) initiated the so-called preincubation period, of varia-
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ble length, which was ended by the addition of substrate starting the
NPP/PDE assay.
3. Results
3.1. Presence of EDTA in the culture-grade preparation of
FGF-1 which inhibited rat liver NPP/PDE
All the NPP/PDE-inhibitory activity present in culture-
grade FGF-1 was recovered in the total volume (Mr = 4000)
of a Sephadex G-100 column, well after the expected elution
volume of FGF-1 (Mr = 15 000^17 000) (results not shown,
and [16]). Stefan et al. have recently suggested that this low-
Mr inhibitor could be EDTA, because its inhibitory activity
was counteracted by Mg2 in the same way as the inhibition
caused by authentic EDTA [16], but they could not chemically
characterize it. We have recorded a 1H-NMR spectrum of the
chromatographic fractions containing the inhibitor, which
showed two major resonance signals with identical chemical
shifts (N 2.49 and N 1.91 ppm) and the same ratio of the
integrated areas (1.9) as the two proton signals of authentic
EDTA under the same conditions. From these spectroscopic
results, it was estimated that culture-grade FGF-1 contained
around 40 nmol EDTA/Wg of protein.
3.2. Time dependence and potentiation by glycine of the
inhibition of rat liver NPP/PDE by EDTA
The e¡ect of EDTA on NPP/PDE was initially studied in
Tris bu¡er and so in the absence of glycine, as usual in our
laboratory and in others [1,3,6^8,18,19]. The enzyme was thus
inhibited by EDTA in a concentration- and time-dependent
manner (Fig. 1A,B). Stefan et al. have reported that 6 WM
EDTA inhibited the PDE activity of rat liver PC-1 by 70%
after 2 min preincubation [16]. However, under these condi-
tions, the results of Fig. 1A,B showed very little or no inhib-
ition. Comparison of our assay conditions with those of Ste-
fan et al. [16] revealed a major di¡erence in the use of,
respectively, 50 mM Tris or 100 mM glycine as bu¡er at pH
9. The results of Fig. 1C,D, versus those of Fig. 1A,B, indicate
that NPP/PDE inhibition by EDTA was strongly enhanced by
glycine, which by itself (up to 25 mM) was not inhibitory. In
the presence of glycine, inhibition was little a¡ected by pre-
incubation (Fig. 1D).
NPP/PDE inhibition by unfractionated culture-grade FGF-
1 or by the low-Mr inhibitor isolated from it by gel ¢ltration
(Section 3.1) showed the same time dependence and potentia-
tion by glycine (results not shown) as the inhibition by au-
thentic EDTA.
3.3. The time-dependent inhibition of NPP/PDE by EDTA was
blocked by the substrate p-nitrophenyl-dTMP
The time-dependent NPP/PDE inhibition by EDTA, seen in
the absence of glycine, was blocked by the substrate p-nitro-
phenyl-dTMP (Fig. 2). In the presence of 30 WM EDTA, when
substrate was added without enzyme preincubation (i.e. pre-
incubation length = 0 min), the little-inhibited rate thus meas-
ured was linear with time for at least 25 min despite the
presence of EDTA in the assay mixture (Fig. 2, closed trian-
gles). In the same experiment, delaying the addition of sub-
strate for as little as 5 min (i.e. preincubation length = 5 min)
resulted in a strongly inhibited, though again linear, reaction
rate (Fig. 2, closed circles). In contrast, 5 min of preincuba-
tion without EDTA did not a¡ect NPP/PDE activity (Fig. 2,
open circles).
4. Discussion
The results prove that, as recently hypothesized [16], the
apparent inhibition of rat liver NPP/PDE by culture-grade
FGF-1 was actually caused by EDTA. In addition, the results
revealed a feature of NPP/PDE inhibition by EDTA which
was previously unrecognized: the inhibitory potency of the
metal chelator was strongly increased by glycine, at millimolar
concentrations of the amino acid. From the EDTA content of
culture-grade FGF-1 estimated by NMR (40 nmol/Wg of pro-
tein) and from the experimental conditions employed by those
who studied the inhibition of rat PC-1 [4,16], one can infer
that the concentrations of EDTA present in experiments
showing 50% PC-1 inhibition by culture-grade FGF-1 [4]
were 0.5^2 WM. Interestingly, that study of rat liver PC-1
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Fig. 1. Inhibition of rat liver NPP/PDE by EDTA: time dependence
and enhancement by glycine. Before assay of PDE activity (Section
2.2), the enzyme was preincubated (Section 2.3) for the length of
time and with the additions indicated in each plot. Activities are ex-
pressed as percentages of the control activity measured without pre-
incubation and in the absence of EDTA and glycine.
Fig. 2. Blocking by substrate of the time-dependent inhibition of rat
liver NPP/PDE by EDTA. The plots represent the reaction courses
of p-nitrophenyl-dTMP hydrolysis in the absence (open symbols) or
in the presence of 30 WM EDTA (closed symbols). Time 0 corre-
sponds in all cases to the addition of a standard amount of NPP/
PDE to reaction mixtures with(out) EDTA. The addition of the
substrate p-nitrophenyl-dTMP was done either immediately before
the addition of NPP/PDE (triangles) or 5 min after it (circles). For
explanation, see Section 3.3.
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was carried out at pH 9, with 100 mM glycine as a bu¡er. Our
results indicate that, if it were not for the enhancing e¡ect of
glycine, the low micromolar concentrations of EDTA and the
very short, 2 min preincubation applied in [4] and [16] would
be insu⁄cient to inhibit NPP/PDE appreciably (see Fig.
1A,B).
From a practical point of view, the results of this work are
a warning that, when studying NPP/PDE enzymes, one should
bear in mind that micromolar traces of EDTA, which would
not normally a¡ect enzyme activity, may be strongly enhanced
by addition of amino acids or other agents having a similar
e¡ect.
The in£uence of divalent cations on NPP/PDE conforma-
tion is supported by experiments showing that EDTA favors
thermal inactivation and proteolytic degradation of PC-1,
whereas divalent cations have the opposite e¡ect [19]. The
time dependence of the NPP/PDE inhibition by EDTA in
the absence of glycine (Fig. 1B) points to the presence of
slowly exchangeable metal ions that are necessary for activity.
The protection exerted by the substrate seems to indicate that
they may be close to (part of) the active site and/or that a
conformational change of NPP/PDE (hindered by substrate
binding) is needed for the exchange to take place. The enhanc-
ing of EDTA inhibition and the loss of its time dependence,
both elicited by glycine, support the occurrence of a confor-
mational change induced or stabilized by the amino acid. This
e¡ect on NPP/PDE conformation may be relevant to the reg-
ulation of the enzyme, independently of the presence of metal
chelators. This does not mean necessarily a direct e¡ect of the
amino acid on the catalytic activity of NPP/PDE. Although
glycine inhibits rat liver NPP/PDE at high concentrations (100
mM; [20] and data from our laboratory), at the concentra-
tions used in this work, glycine by itself did not a¡ect the
PDE activity of NPP/PDE (results not shown). However, it
is possible that NPP/PDE has biological functions not de-
pendent on its enzymatic activity, and the change promoted
by glycine may a¡ect them. In this connection, it is interesting
that the inhibition of insulin receptor phosphorylation is eli-
cited both by wild-type PC-1 and by a mutant devoid of PDE
activity [14,21].
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